Toll Free: 1-888-928-9744
Published: Jan, 2018 | Pages:
106 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
In this report, the United States Prostate Cancer Diagnostics market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Prostate Cancer Diagnostics in these regions, from 2013 to 2025 (forecast). United States Prostate Cancer Diagnostics market competition by top manufacturers/players, with Prostate Cancer Diagnostics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Genomic Health Abbott OPKO Siemens Healthcare DiaSorin bioMeriux Roche MDx Health Beckman Coulter Myriad Genetics Ambry Genetics On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Tumor Biomarker Tests Imaging Biopsy Other On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including Under 55 Years Old 55-75 Years Old Above 75 Years Old If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents United States Prostate Cancer Diagnostics Market Report 2018 1 Prostate Cancer Diagnostics Overview 1.1 Product Overview and Scope of Prostate Cancer Diagnostics 1.2 Classification of Prostate Cancer Diagnostics by Product Category 1.2.1 United States Prostate Cancer Diagnostics Market Size (Sales Volume) Comparison by Type (2013-2025) 1.2.2 United States Prostate Cancer Diagnostics Market Size (Sales Volume) Market Share by Type (Product Category) in 2017 1.2.3 Tumor Biomarker Tests 1.2.4 Imaging 1.2.5 Biopsy 1.2.6 Other 1.3 United States Prostate Cancer Diagnostics Market by Application/End Users 1.3.1 United States Prostate Cancer Diagnostics Market Size (Consumption) and Market Share Comparison by Application (2013-2025) 1.3.2 Under 55 Years Old 1.3.3 55-75 Years Old 1.3.4 Above 75 Years Old 1.4 United States Prostate Cancer Diagnostics Market by Region 1.4.1 United States Prostate Cancer Diagnostics Market Size (Value) Comparison by Region (2013-2025) 1.4.2 The West Prostate Cancer Diagnostics Status and Prospect (2013-2025) 1.4.3 Southwest Prostate Cancer Diagnostics Status and Prospect (2013-2025) 1.4.4 The Middle Atlantic Prostate Cancer Diagnostics Status and Prospect (2013-2025) 1.4.5 New England Prostate Cancer Diagnostics Status and Prospect (2013-2025) 1.4.6 The South Prostate Cancer Diagnostics Status and Prospect (2013-2025) 1.4.7 The Midwest Prostate Cancer Diagnostics Status and Prospect (2013-2025) 1.5 United States Market Size (Value and Volume) of Prostate Cancer Diagnostics (2013-2025) 1.5.1 United States Prostate Cancer Diagnostics Sales and Growth Rate (2013-2025) 1.5.2 United States Prostate Cancer Diagnostics Revenue and Growth Rate (2013-2025) 2 United States Prostate Cancer Diagnostics Market Competition by Players/Suppliers 2.1 United States Prostate Cancer Diagnostics Sales and Market Share of Key Players/Suppliers (2013-2018) 2.2 United States Prostate Cancer Diagnostics Revenue and Share by Players/Suppliers (2013-2018) 2.3 United States Prostate Cancer Diagnostics Average Price by Players/Suppliers (2013-2018) 2.4 United States Prostate Cancer Diagnostics Market Competitive Situation and Trends 2.4.1 United States Prostate Cancer Diagnostics Market Concentration Rate 2.4.2 United States Prostate Cancer Diagnostics Market Share of Top 3 and Top 5 Players/Suppliers 2.4.3 Mergers & Acquisitions, Expansion in United States Market 2.5 United States Players/Suppliers Prostate Cancer Diagnostics Manufacturing Base Distribution, Sales Area, Product Type 3 United States Prostate Cancer Diagnostics Sales (Volume) and Revenue (Value) by Region (2013-2018) 3.1 United States Prostate Cancer Diagnostics Sales and Market Share by Region (2013-2018) 3.2 United States Prostate Cancer Diagnostics Revenue and Market Share by Region (2013-2018) 3.3 United States Prostate Cancer Diagnostics Price by Region (2013-2018) 4 United States Prostate Cancer Diagnostics Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018) 4.1 United States Prostate Cancer Diagnostics Sales and Market Share by Type (Product Category) (2013-2018) 4.2 United States Prostate Cancer Diagnostics Revenue and Market Share by Type (2013-2018) 4.3 United States Prostate Cancer Diagnostics Price by Type (2013-2018) 4.4 United States Prostate Cancer Diagnostics Sales Growth Rate by Type (2013-2018) 5 United States Prostate Cancer Diagnostics Sales (Volume) by Application (2013-2018) 5.1 United States Prostate Cancer Diagnostics Sales and Market Share by Application (2013-2018) 5.2 United States Prostate Cancer Diagnostics Sales Growth Rate by Application (2013-2018) 5.3 Market Drivers and Opportunities 6 United States Prostate Cancer Diagnostics Players/Suppliers Profiles and Sales Data 6.1 Genomic Health 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Prostate Cancer Diagnostics Product Category, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 Genomic Health Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018) 6.1.4 Main Business/Business Overview 6.2 Abbott 6.2.2 Prostate Cancer Diagnostics Product Category, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Abbott Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018) 6.2.4 Main Business/Business Overview 6.3 OPKO 6.3.2 Prostate Cancer Diagnostics Product Category, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 OPKO Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018) 6.3.4 Main Business/Business Overview 6.4 Siemens Healthcare 6.4.2 Prostate Cancer Diagnostics Product Category, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Siemens Healthcare Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018) 6.4.4 Main Business/Business Overview 6.5 DiaSorin 6.5.2 Prostate Cancer Diagnostics Product Category, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 DiaSorin Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018) 6.5.4 Main Business/Business Overview 6.6 bioMeriux 6.6.2 Prostate Cancer Diagnostics Product Category, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 bioMeriux Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018) 6.6.4 Main Business/Business Overview 6.7 Roche 6.7.2 Prostate Cancer Diagnostics Product Category, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 Roche Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018) 6.7.4 Main Business/Business Overview 6.8 MDx Health 6.8.2 Prostate Cancer Diagnostics Product Category, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 MDx Health Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018) 6.8.4 Main Business/Business Overview 6.9 Beckman Coulter 6.9.2 Prostate Cancer Diagnostics Product Category, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 Beckman Coulter Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018) 6.9.4 Main Business/Business Overview 6.10 Myriad Genetics 6.10.2 Prostate Cancer Diagnostics Product Category, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 Myriad Genetics Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018) 6.10.4 Main Business/Business Overview 6.11 Ambry Genetics 7 Prostate Cancer Diagnostics Manufacturing Cost Analysis 7.1 Prostate Cancer Diagnostics Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Prostate Cancer Diagnostics 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Prostate Cancer Diagnostics Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Prostate Cancer Diagnostics Major Manufacturers in 2017 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 United States Prostate Cancer Diagnostics Market Size (Value and Volume) Forecast (2018-2025) 11.1 United States Prostate Cancer Diagnostics Sales Volume, Revenue Forecast (2018-2025) 11.2 United States Prostate Cancer Diagnostics Sales Volume Forecast by Type (2018-2025) 11.3 United States Prostate Cancer Diagnostics Sales Volume Forecast by Application (2018-2025) 11.4 United States Prostate Cancer Diagnostics Sales Volume Forecast by Region (2018-2025) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer
List of Tables and Figures Figure Product Picture of Prostate Cancer Diagnostics Figure United States Prostate Cancer Diagnostics Market Size (K Pcs) by Type (2013-2025) Figure United States Prostate Cancer Diagnostics Sales Volume Market Share by Type (Product Category) in 2017 Figure Tumor Biomarker Tests Product Picture Figure Imaging Product Picture Figure Biopsy Product Picture Figure Other Product Picture Figure United States Prostate Cancer Diagnostics Market Size (K Pcs) by Application (2013-2025) Figure United States Sales Market Share of Prostate Cancer Diagnostics by Application in 2017 Figure Under 55 Years Old Examples Table Key Downstream Customer in Under 55 Years Old Figure 55-75 Years Old Examples Table Key Downstream Customer in 55-75 Years Old Figure Above 75 Years Old Examples Table Key Downstream Customer in Above 75 Years Old Figure United States Prostate Cancer Diagnostics Market Size (Million USD) by Region (2013-2025) Figure The West Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate (2013-2025) Figure Southwest Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate (2013-2025) Figure The Middle Atlantic Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate (2013-2025) Figure New England Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate (2013-2025) Figure The South of US Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate (2013-2025) Figure The Midwest Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate (2013-2025) Figure United States Prostate Cancer Diagnostics Sales (K Pcs) and Growth Rate (2013-2025) Figure United States Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate (2013-2025) Figure United States Prostate Cancer Diagnostics Market Major Players Product Sales Volume (K Pcs) (2013-2018) Table United States Prostate Cancer Diagnostics Sales (K Pcs) of Key Players/Suppliers (2013-2018) Table United States Prostate Cancer Diagnostics Sales Share by Players/Suppliers (2013-2018) Figure 2017 United States Prostate Cancer Diagnostics Sales Share by Players/Suppliers Figure 2017 United States Prostate Cancer Diagnostics Sales Share by Players/Suppliers Figure United States Prostate Cancer Diagnostics Market Major Players Product Revenue (Million USD) (2013-2018) Table United States Prostate Cancer Diagnostics Revenue (Million USD) by Players/Suppliers (2013-2018) Table United States Prostate Cancer Diagnostics Revenue Share by Players/Suppliers (2013-2018) Figure 2017 United States Prostate Cancer Diagnostics Revenue Share by Players/Suppliers Figure 2017 United States Prostate Cancer Diagnostics Revenue Share by Players/Suppliers Table United States Market Prostate Cancer Diagnostics Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018) Figure United States Market Prostate Cancer Diagnostics Average Price (USD/Pcs) of Key Players/Suppliers in 2017 Figure United States Prostate Cancer Diagnostics Market Share of Top 3 Players/Suppliers Figure United States Prostate Cancer Diagnostics Market Share of Top 5 Players/Suppliers Table United States Players/Suppliers Prostate Cancer Diagnostics Manufacturing Base Distribution and Sales Area Table United States Players/Suppliers Prostate Cancer Diagnostics Product Category Table United States Prostate Cancer Diagnostics Sales (K Pcs) by Region (2013-2018) Table United States Prostate Cancer Diagnostics Sales Share by Region (2013-2018) Figure United States Prostate Cancer Diagnostics Sales Share by Region (2013-2018) Figure United States Prostate Cancer Diagnostics Sales Market Share by Region in 2017 Table United States Prostate Cancer Diagnostics Revenue (Million USD) and Market Share by Region (2013-2018) Table United States Prostate Cancer Diagnostics Revenue Share by Region (2013-2018) Figure United States Prostate Cancer Diagnostics Revenue Market Share by Region (2013-2018) Figure United States Prostate Cancer Diagnostics Revenue Market Share by Region in 2017 Table United States Prostate Cancer Diagnostics Price (USD/Pcs) by Region (2013-2018) Table United States Prostate Cancer Diagnostics Sales (K Pcs) by Type (2013-2018) Table United States Prostate Cancer Diagnostics Sales Share by Type (2013-2018) Figure United States Prostate Cancer Diagnostics Sales Share by Type (2013-2018) Figure United States Prostate Cancer Diagnostics Sales Market Share by Type in 2017 Table United States Prostate Cancer Diagnostics Revenue (Million USD) and Market Share by Type (2013-2018) Table United States Prostate Cancer Diagnostics Revenue Share by Type (2013-2018) Figure Revenue Market Share of Prostate Cancer Diagnostics by Type (2013-2018) Figure Revenue Market Share of Prostate Cancer Diagnostics by Type in 2017 Table United States Prostate Cancer Diagnostics Price (USD/Pcs) by Types (2013-2018) Figure United States Prostate Cancer Diagnostics Sales Growth Rate by Type (2013-2018) Table United States Prostate Cancer Diagnostics Sales (K Pcs) by Application (2013-2018) Table United States Prostate Cancer Diagnostics Sales Market Share by Application (2013-2018) Figure United States Prostate Cancer Diagnostics Sales Market Share by Application (2013-2018) Figure United States Prostate Cancer Diagnostics Sales Market Share by Application in 2017 Table United States Prostate Cancer Diagnostics Sales Growth Rate by Application (2013-2018) Figure United States Prostate Cancer Diagnostics Sales Growth Rate by Application (2013-2018) Table Genomic Health Basic Information List Table Genomic Health Prostate Cancer Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Genomic Health Prostate Cancer Diagnostics Sales Growth Rate (2013-2018) Figure Genomic Health Prostate Cancer Diagnostics Sales Market Share in United States (2013-2018) Figure Genomic Health Prostate Cancer Diagnostics Revenue Market Share in United States (2013-2018) Table Abbott Basic Information List Table Abbott Prostate Cancer Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Abbott Prostate Cancer Diagnostics Sales Growth Rate (2013-2018) Figure Abbott Prostate Cancer Diagnostics Sales Market Share in United States (2013-2018) Figure Abbott Prostate Cancer Diagnostics Revenue Market Share in United States (2013-2018) Table OPKO Basic Information List Table OPKO Prostate Cancer Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure OPKO Prostate Cancer Diagnostics Sales Growth Rate (2013-2018) Figure OPKO Prostate Cancer Diagnostics Sales Market Share in United States (2013-2018) Figure OPKO Prostate Cancer Diagnostics Revenue Market Share in United States (2013-2018) Table Siemens Healthcare Basic Information List Table Siemens Healthcare Prostate Cancer Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Siemens Healthcare Prostate Cancer Diagnostics Sales Growth Rate (2013-2018) Figure Siemens Healthcare Prostate Cancer Diagnostics Sales Market Share in United States (2013-2018) Figure Siemens Healthcare Prostate Cancer Diagnostics Revenue Market Share in United States (2013-2018) Table DiaSorin Basic Information List Table DiaSorin Prostate Cancer Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure DiaSorin Prostate Cancer Diagnostics Sales Growth Rate (2013-2018) Figure DiaSorin Prostate Cancer Diagnostics Sales Market Share in United States (2013-2018) Figure DiaSorin Prostate Cancer Diagnostics Revenue Market Share in United States (2013-2018) Table bioMeriux Basic Information List Table bioMeriux Prostate Cancer Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure bioMeriux Prostate Cancer Diagnostics Sales Growth Rate (2013-2018) Figure bioMeriux Prostate Cancer Diagnostics Sales Market Share in United States (2013-2018) Figure bioMeriux Prostate Cancer Diagnostics Revenue Market Share in United States (2013-2018) Table Roche Basic Information List Table Roche Prostate Cancer Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Roche Prostate Cancer Diagnostics Sales Growth Rate (2013-2018) Figure Roche Prostate Cancer Diagnostics Sales Market Share in United States (2013-2018) Figure Roche Prostate Cancer Diagnostics Revenue Market Share in United States (2013-2018) Table MDx Health Basic Information List Table MDx Health Prostate Cancer Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure MDx Health Prostate Cancer Diagnostics Sales Growth Rate (2013-2018) Figure MDx Health Prostate Cancer Diagnostics Sales Market Share in United States (2013-2018) Figure MDx Health Prostate Cancer Diagnostics Revenue Market Share in United States (2013-2018) Table Beckman Coulter Basic Information List Table Beckman Coulter Prostate Cancer Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Beckman Coulter Prostate Cancer Diagnostics Sales Growth Rate (2013-2018) Figure Beckman Coulter Prostate Cancer Diagnostics Sales Market Share in United States (2013-2018) Figure Beckman Coulter Prostate Cancer Diagnostics Revenue Market Share in United States (2013-2018) Table Myriad Genetics Basic Information List Table Myriad Genetics Prostate Cancer Diagnostics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Myriad Genetics Prostate Cancer Diagnostics Sales Growth Rate (2013-2018) Figure Myriad Genetics Prostate Cancer Diagnostics Sales Market Share in United States (2013-2018) Figure Myriad Genetics Prostate Cancer Diagnostics Revenue Market Share in United States (2013-2018) Table Ambry Genetics Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Prostate Cancer Diagnostics Figure Manufacturing Process Analysis of Prostate Cancer Diagnostics Figure Prostate Cancer Diagnostics Industrial Chain Analysis Table Raw Materials Sources of Prostate Cancer Diagnostics Major Players/Suppliers in 2017 Table Major Buyers of Prostate Cancer Diagnostics Table Distributors/Traders List Figure United States Prostate Cancer Diagnostics Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025) Figure United States Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure United States Prostate Cancer Diagnostics Price (USD/Pcs) Trend Forecast (2018-2025) Table United States Prostate Cancer Diagnostics Sales Volume (K Pcs) Forecast by Type (2018-2025) Figure United States Prostate Cancer Diagnostics Sales Volume (K Pcs) Forecast by Type (2018-2025) Figure United States Prostate Cancer Diagnostics Sales Volume (K Pcs) Forecast by Type in 2025 Table United States Prostate Cancer Diagnostics Sales Volume (K Pcs) Forecast by Application (2018-2025) Figure United States Prostate Cancer Diagnostics Sales Volume (K Pcs) Forecast by Application (2018-2025) Figure United States Prostate Cancer Diagnostics Sales Volume (K Pcs) Forecast by Application in 2025 Table United States Prostate Cancer Diagnostics Sales Volume (K Pcs) Forecast by Region (2018-2025) Table United States Prostate Cancer Diagnostics Sales Volume Share Forecast by Region (2018-2025) Figure United States Prostate Cancer Diagnostics Sales Volume Share Forecast by Region (2018-2025) Figure United States Prostate Cancer Diagnostics Sales Volume Share Forecast by Region in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.